All recorded activity
- Rounds participated in
- 2
- Confirmed lead rounds
- —
2 roles undisclosed- New companies
- 2
First participation on record · 0 follow-on- Funding in participating rounds
- $174.8M
2 disclosed · full round size, not this investor’s share
Rounds
2 in all activityRQ BioDevelops antibody therapies to prevent seasonal influenza in high-risk and immunocompromised patients
Role not disclosedExcivaDevelops novel therapies for behavioral symptoms associated with Alzheimer's Disease
Role not disclosed